This Week in Psychedelics - 1.21.22

Cannabis

• Thailand Plans to Make Marijuana Legal, Scrapping Jail Terms and Fines for Possession (Bloomberg)

• U.S. Senate Candidate Smokes Marijuana Blunt In Campaign Ad About Harms Of Criminalization (Marijuana Moment)

• After One Year As President, Biden’s Marijuana Promises Remain Unfulfilled (Marijuana Moment)

• Mississippi House Approves Medical Marijuana Bill With Amendments (Marijuana Moment)

• It’s high time that people caught with cannabis be spared jail, declare public (The Telegraph)

• London’s Cannabis Diversion Plan Draws Political Fire (Filter)

• Kansas Medical Marijuana Hearings Cancelled After Senate GOP Leader Reroutes House-Passed Bill (Marijuana Moment)

• What Is THC-O Acetate, And Why Is It Getting Attention? (Forbes)

• Study Shows Cannabis was Food Staple for Ancient Chinese Dynasty (High Times)

• Most Americans Predict Biden Won’t Uphold Marijuana Decriminalization Promise In 2022, Poll Finds (Marijuana Moment)

• Austin, Texas Cannabis Decriminalization Initiative Set for Ballot in May (High Times)

• Rhode Island Governor Includes Marijuana Legalization And Expungements In Budget Request (Marijuana Moment)

• Cannabis use impacts cognitive ability beyond intoxication: study (CTV News)

• Minnesota Democratic Leaders Preview Marijuana Legalization Plan For 2022 (Marijuana Moment)

• Ohio Advocates Submit Additional Signatures for Cannabis Proposal (High Times)

• Kentucky Addresses Cannabis Reform Through New Legislation (High Times)

• Canada might be home to the world’s first airport dispensary (Leafly)

• Nebraska Activists Say New GOP Medical Marijuana Bill Is A ‘Poison Pill’ Meant To Detract From Ballot Efforts (Marijuana Moment)

• South Dakota Governor Demands Cannabis Advocates Cover Legal Costs (High Times)

• Banking Activity Increases In States That Legalize Marijuana, Study Finds (Marijuana Moment)

• Cannabis Companies Target Teens on Social Media, Study Claims (High Times)

• Cloudastructure’s Artificial Intelligence is Revolutionizing Cannabis Surveillance (High Times)

Magic Mushrooms

• Controversial Kansas Lawmaker Files Bill To Legalize Psilocybin Possession And Cultivation (Marijuana Moment)

• Bipartisan Congressional Lawmakers Tell DEA To Allow Psilocybin Treatment For Terminal Patients (Marijuana Moment)

• New Research Probes Psilocybin’s Effect on Suicidality (Lucid News)

• Optimi Health Submits Natural Psilocybin Combined Drug Delivery and Extraction Formulations for Provisional Patent (Psilocybin Alpha)

MDMA

• Why MDMA Makes You Horny (VICE)

• Use of ecstasy and cocaine drops during pandemic (Irish Examiner)

• Numinus Announces Key Milestones in MAPS-Sponsored MDMA-Assisted Therapy for PTSD Clinical Trial (Psilocybin Alpha)

• The MDMA Comedown: Why Coming Down From Molly Feels So Bad (DoubleBlind)

• A psychedelic trip to recovery: How psychedelics can help treat PTSD (The Ubyssey)

DMT

• Algernon Pharmaceuticals Files for Clinical Trial and Ethics Approval for Phase 1 DMT Human Stroke Study (Psilocybin Alpha)

• Why Do People See Elves And Other "Entities" When They Smoke DMT? (IFLScience)

Ayahuasca

• Do Ayahuasca Healing Ceremonies Really Work? (Psychology Today)

Morning Glory Seeds

• What Is LSA? Your Guide To The Complicated Psychedelic (Healing Maps)

Novel Psychoactive Substances

• BetterLife Receives FDA Response On Its Pre-IND Application For Major Depressive Disorder (MDD) Treatment With BETR-001 (Psilocybin Alpha)

Synthetic Cannabinoids

• Study: Cannabinoids May Help Prevent and Treat Peanut Allergies (The Marijuana Herald)

• Trial Will Test Synthetic Cannabinoid for Weight Loss in Obesity (Medscape)

• Dyadic Introduces Novel Method to Produce Synthetic Cannabinoids and Precursors Utilizing C1 Cell Line Production Platform and Patent Pending Process (GlobeNewswire)

Ketamine

• Plastic Surgeons Are Using Ketamine to Make Nose Jobs More Pleasant (Allure)

Datura

• Are your food grains adulterated with poisonous dhatura (Times of India)

Miscellaneous

• DEA Proposes Adding 5 More Psychedelics to Schedule 1 Controlled Substances (Psychedelic Spotlight)

• Psychedelic use is only “weakly” associated with psychosis-like symptoms, according to new research (PsyPost)

• Utah Lawmaker Files Bill To Explore Therapeutic Use of Psychedelics (High Times)

• Psychedelics ‘Train Has Left the Station’ Says Federal Drug Official as More States Seek Access (Psychedelic Spotlight)

• Sydney Researchers Awarded Over $2.2 Million By Australian Government To Study MDMA, Psilocybin (Forbes)

• Missouri Lawmaker Files Bill To Decriminalize Low-Level Drug Possession (Marijuana Moment)

• Psychedelic legalization now (The New Amsterdam Psychedelic Law Blog)

• Psygen Receives Dealer’s Licence To Become Canada’s First Dedicated Psychedelics Manufacturing Facility (The Dales Report)

• Allowing psychedelic assisted therapy is an enlightened move, medical experts say (National Post)

• Majority of Mental Health Patients Support Access to Psychedelics, Survey Finds (Psychedelic Spotlight)

• Psychedelic Company Highlights in 2021 (Psilocybin Alpha)

• Talking Drugs Updates from Eastern Europe and Central Asia (TalkingDrugs)

• Pandemic Tripping With Psychedelics (Green Market Report)

• What are the potential risks of microdosing psychedelics? (Leafly)

• Cybin Set to Measure Psychedelic Effects on the Brain Using Kernel Flow’s Revolutionary Technology (Psychedelic Spotlight)

• Peek Inside Philadelphia’s Psychedelics Revolution (Philadelphia Magazine)

• Psychedelic Science Leader Eleusis to Become Public Company in Merger with Silver Spike Acquisition Corp. II (Psilocybin Alpha)

• How Port Townsend, Washington, Decriminalized Psychedelics (Filter)

• Athletes and Psychedelics: Mental Health and Performance (Truffle Report)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 8.20.21

Cannabis

• Gallup Poll Finds Almost Half Of US Adults Have Tried Marijuana (High Times)

• Meet THC-O, a hemp-derived compound three times stronger than THC (Leafly)

• Study Shows Cancer Patients Consume Less Cannabis Than General Public (High Times)

• Ohio Activists Submit Revised Marijuana Legalization Petition For 2022 Ballot After State Rejected Earlier Version (Marijuana Moment)

• Consumption Lounges on the Horizon for Nevada (High Times)

• NBA Star Kevin Durant Teams Up With Weedmaps To Destigmatize Marijuana In Sports (Marijuana Moment)

LSD

• Exploring the Role of Serotonin 2A Activation in LSD’s Effects on Empathy (Psychedelic Science Review)

Magic Mushrooms

• Diamond Therapeutics Announces Health Canada Approval of Clinical Trial with Low-Dose Psilocybin (Psilocybin Alpha)

DMT

• Biomind Labs to Advance a Phase II Clinical Trial on DMT for Treatment-Resistant Depression (Business Wire)

Ayahuasca

• The Sustainability of Ayahuasca (Reality Sandwich)

• Ayahuasca and Femininity (Reality Sandwich)

• Can Ayahuasca Alter Personality? (Reality Sandwich)

5-MeO-DMT

• Psychedelic toad venom could soon be a clinical treatment for depression (Sifted)

Salvia Divinorum

• Developing a Novel Psychedelic: Salvinorin A (Psychiatric Times)

Synthetic Cannabinoids

• Belfast: Youths Hospitalised After Unknowingly Vaping Spice Instead of CBD (Vaping Post)

Ketamine

• A New Ketamine Test Kit is Now Available (DanceSafe)

• What Happens If Ketamine Treatment Doesn’t Work? (Healing Maps)

• The Pros And Cons Of Ketamine For Anxiety: Here’s What We Know (Healing Maps)

PCP

• How PCP Became A Weapon of Police Propaganda [Part 2] (Psychedelics Today)

Miscellaneous

• Mixing Psychedelics and SSRIs Is Generally Safe, with Significant Exceptions (Lucid News)

• At-Home Genetic Testing Can’t Tell You If You’re Going to Have a Bad Trip (VICE)

• California Bill To Legalize Possession Of Psychedelics Clears Another Hurdle But Faces Key Challenge Next Week (Marijuana Moment)

• Rat poison is just one of the potentially dangerous substances likely to be mixed into illicit drugs (The Conversation)

• Denver Launches the Nation’s First Psychedelic Harm Reduction Training for First Responders (Lucid News)

• Ann Arbor City Council Declares Psychedelics Awareness Month For September (Marijuana Moment)

• Tech Startup Tripp To Use Virtual Reality To Improve Psychedelic Therapy (Forbes)

• Beckley Psytech completes oversubscribed $80m (£58m) fundraise to develop portfolio of psychedelic medicine breakthroughs (Beckley Psytech)

• Chacruna Launches Indigenous Reciprocity Initiative (Truffle Report)

• Psychedelics Can Help Mitigate Symptoms Of Racial Trauma For People Of Color, Study Finds (Marijuana Moment)

• Media Company DoubleBlind Is The Master Class Of Psychedelics (Forbes)

• Israeli team aims to treat neurological disorders with psychedelics (The Jerusalem Post)

• Washington Governor Unveils New Process To Commute Hundreds Of Drug Possession Sentences (Marijuana Moment)

• 9 Celebrities on Their Life-Changing Psychedelic Experiences (DoubleBlind)

• Whole-Body Effects of Psychedelics Part 2 – Blood and Immune System (Psychedelic Science Review)

• DEA Seizes Life Savings of New Orleans Grandfather Without Charging Him With a Crime (Reason)

• Can Harm Reduction Reform the Drug Courts? (Filter)

• Kathleen Harrison: Wisdom, Endurance, and Hope – Reflections from a Psychedelic Woman (Chacruna)

• Moving Deckchairs On The Titanic: Drug Policy Reform in the UK (TalkingDrugs)

• Post-Traumatic Growth With Psychedelics (Truffle Report)

• Psychedelics, Out Of Body Experiences, and Lucid Dreaming (Reality Sandwich)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.